We are live on
!
Find out more
NED
Nancy E. Dempze Portfolio holdings
AUM
$182M
1-Year Est. Return
16.09%
This Fund
S&P 500
This Quarter
Est. Return
+9.29%
1 Year Est. Return
+16.09%
3 Year Est. Return
+59.1%
5 Year Est. Return
+78.95%
10 Year Est. Return
+300.76%
AUM
$120M
AUM Growth
+$8.21M
(+7.4%)
Cap. Flow
-$2.36M
Cap. Flow
% of AUM
-1.97%
Top 10 Holdings %
Top 10 Hldgs %
38.46%
Holding
64
New
–
Increased
17
Reduced
23
Closed
6
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
UnitedHealth
UNH
|
+$221K |
| 2 |
Home Depot
HD
|
+$143K |
| 3 |
Abbott
ABT
|
+$140K |
| 4 |
Amazon
AMZN
|
+$112K |
| 5 |
Chevron
CVX
|
+$59.7K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Walt Disney
DIS
|
+$757K |
| 2 |
Illumina
ILMN
|
+$593K |
| 3 |
Novartis
NVS
|
+$338K |
| 4 |
Danaher
DHR
|
+$329K |
| 5 |
CVS Health
CVS
|
+$299K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 27.28% |
| 2 | Healthcare | 20.02% |
| 3 | Industrials | 11.96% |
| 4 | Consumer Discretionary | 10.18% |
| 5 | Financials | 5.29% |
Similar funds
RS
CFG
CFG
TFP
AFS
EMB
CIA
HWM
Nancy E. Dempze's Q4 2023 Portfolio in Review
As of Q4 2023, Nancy E. Dempze held 64 positions worth $120M, up 7.4% from $111M the previous quarter. Its ten largest holdings account for 38% of the portfolio.
Nancy E. Dempze's Q4 2023 filing shows 17 increased, 23 reduced and 6 closed positions. The largest sale was Walt Disney, an estimated $757K.
By sector, the portfolio is most concentrated in Technology at 27% of assets, up from 26% a quarter earlier, followed by Healthcare and Industrials.
- Nancy E. Dempze added most to UnitedHealth in Q4 2023, an estimated $221K increase.
- Nancy E. Dempze's biggest Q4 2023 reduction was Novartis, cutting an estimated $338K.
- Nancy E. Dempze fully exited Walt Disney in Q4 2023, selling an estimated $757K.
- Nancy E. Dempze's ten largest holdings make up 38% of its $120M portfolio in Q4 2023.
- Nancy E. Dempze opened 0 new positions and closed 6 in Q4 2023.
- Nancy E. Dempze's portfolio value rose 7.4% quarter-over-quarter to $120M.
Based on Nancy E. Dempze's 13F filing for Q4 2023, filed 14 Feb 2024.